Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,090 | 2,226 | -2,320 | 1,490 | -9,283 |
| Depreciation Amortization | 824 | 411 | 521 | 283 | -389 |
| Accounts receivable | 472 | 1,159 | -147 | 290 | -53 |
| Other Working Capital | 2,127 | 1,543 | -597 | -268 | 996 |
| Other Operating Activity | -13,907 | -14,727 | -4,441 | -5,000 | 1,484 |
| Operating Cash Flow | $-12,574 | $-9,388 | $-6,984 | $-3,205 | $-7,245 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 811 | -2,584 | -4,542 | -323 | 8,294 |
| PPE Investments | 12,642 | 12,761 | 11,497 | 4,691 | -1,648 |
| Net Acquisitions | -28 | -28 | -21 | -11 | -654 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -38 |
| Investing Cash Flow | $13,425 | $10,149 | $6,934 | $4,357 | $5,954 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,039 | 1,039 | 722 | 594 | 1,120 |
| Debt Repayment | -847 | -608 | -382 | -176 | -426 |
| Common Stock Issued | 29 | 26 | 26 | 24 | 575 |
| Common Stock Repurchased | -1,052 | -1,052 | -1,043 | -1,043 | -2,266 |
| Financing Cash Flow | $-831 | $-595 | $-677 | $-601 | $-997 |
| Beginning Cash Position | 2,820 | 2,820 | 2,820 | 2,820 | 5,108 |
| End Cash Position | 2,840 | 2,986 | 2,093 | 3,371 | 2,820 |
| Net Cash Flow | $20 | $166 | $-727 | $551 | $-2,288 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,574 | -9,388 | -6,984 | -3,205 | -7,245 |
| Capital Expenditure | -789 | -673 | -463 | -309 | -1,743 |
| Free Cash Flow | -13,363 | -10,061 | -7,447 | -3,514 | -8,988 |